Authors:
KREMENOPOULOS G
SOUBASI V
TSANTALI C
DIAMANTI E
TSAKIRIS D
Citation: G. Kremenopoulos et al., THE BEST TIMING OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION INANEMIA OF PREMATURITY - A RANDOMIZED CONTROLLED-STUDY, International journal of pediatric hematology/oncology, 4(4), 1997, pp. 373-383
Authors:
SOUBASI V
KREMENOPOULOS G
DIAMANTI E
TSANTALI C
SARAFIDIS K
TSAKIRIS D
Citation: V. Soubasi et al., INDUCTION OF FETAL HEMOGLOBIN BY EPO GIVEN IN PRETERM NEONATES FOR THE PREVENTION OF ANEMIA OF PREMATURITY, International journal of pediatric hematology/oncology, 2(3), 1995, pp. 205-209
Authors:
SPANDOU E
SOUBASI V
GUIBATZIAMPIRI O
KARKAVELAS G
KAIKIASTARA A
DOUKAS V
PAPADIMITRIOU C
Citation: E. Spandou et al., MAGNESIUM MONOTHERAPY OR IN COMBINATION WITH KETAMINE IN PERINATAL HYPOXIC-ISCHEMIC BRAIN DAMAGE(PRELIMINARY STUDY), Pediatric research, 38(3), 1995, pp. 455-455
Authors:
SOUBASI V
KREMENOPOULOS G
DIAMANDI E
SARAFIDIS K
TSANTALI C
TSAKIRIS D
Citation: V. Soubasi et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON OVERALL REDUCTION OF ERYTHROCYTE TRANSFUSIONS IN PRETERM INFANTS, Pediatric research, 37(4), 1995, pp. 238-238
Authors:
SOUBASI V
KREMENOPOULOS G
DIAMANTI E
TSANTALI C
SARAFIDIS K
TSAKIRIS D
Citation: V. Soubasi et al., FOLLOW-UP OF VERY-LOW-BIRTH-WEIGHT INFANTS AFTER ERYTHROPOIETIN TREATMENT TO PREVENT ANEMIA OF PREMATURITY, The Journal of pediatrics, 127(2), 1995, pp. 291-297
Authors:
SOUBASI V
KREMENOPOULOS G
DIAMANTI E
TSANTALI C
SARAFIDIS K
TSAKIRIS D
Citation: V. Soubasi et al., WHICH IS THE BEST TIMING OF EPO ADMINISTRATION IN ANEMIA OF PREMATURITY (AOP) - RANDOMIZED CONTROLLED-STUDY, Pediatric research, 36(1), 1994, pp. 10000038-10000038
Authors:
SOUBASI V
KREMENOPOULOS G
DIAMANDI E
TSANTALI C
TSAKIRIS D
Citation: V. Soubasi et al., IN WHICH NEONATES DOES EARLY RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT PREVENT ANEMIA OF PREMATURITY - RESULTS OF A RANDOMIZED, CONTROLLED-STUDY, Pediatric research, 34(5), 1993, pp. 675-679